CLABF CORE ONE LABS INC
- 0.143520
- -0.007880-5.20%
CORE ONE LABS INC News
Core One Labs Signs Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin
Psyched: Germany Ships LSD Prodrugs Via DHL, Minneapolis Decriminalizes, Wiz Khalifa's Magic Pitch & More
Minneapolis Mayor Deprioritizes Psychedelics: 'We Should Be In The Business Of Helping People' Minneapolis Mayor Jacob Frey recently signed an executive order effectively deprioritizing criminal prose
Core One Labs Enters Into LOI For First Sale Of Its Psychedelic Compounds
GMP Drug Inc., a wholly-owned subsidiary of Core One Labs Inc. (OTCQB:CLABF) (CSE:COOL)(Frankfurt:LD6) (WKN: A3CSSU) has entered into a non-binding letter of intent with Zollaris Laboratories Corporat
Core One In Talks With Multiple Companies To Supply Psilocybin
Core One Labs Inc. (OTCQB:CLABF) (CSE:COOL)(Frankfurt:LD6), (WKN:A3CSSU) announced that it is in discussions with several pharmaceutical laboratories and research organizations to supply them with act
Core One's Awakened Lays The Groundwork For The Large-Scale Production Of Psychedelic Compounds With Synthetic Production Of Psilocin
Core One Labs Inc. (OTCQB:CLABF) (CSE:COOL)(Frankfurt:LD6) (WKN:A3CSSU) announced that its wholly-owned subsidiary, Awakened Biosciences Inc. has successfully completed the first synthetic production
Short Interest in Core One Labs Inc. (OTCMKTS:CLABF) Decreases By 42.9%
Core One Labs Inc. (OTCMKTS:CLABF – Get Rating) was the recipient of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 2,000 shares, a decl
Across The Globe: Psychedelic Trials To Treat Late-Stage Cancer, Alzheimer's Begin
Core One Labs' Akome Partners To Study Next-Gen Psychedelics A subsidiary of Core One Labs (OTCQB:CLABF) has signed a contract with Fundació Bosh I Gimpera to begin second-phase studies evaluating th
Psyched: States With Psychedelics Legalization Bills, Next-Gen Molecule For Addiction Treatment And More
Legalizing Psychedelics From New York To Washington And Five In Between: Which State Will Go First? Legislators in seven U.S. states are introducing psychedelics bills as they seek to emulate measures
Here Are The Latest Psychedelics Partnerships From Production & Supply Chain To Community Action
Let's do a quick tour of some of the latest announcements made by psychedelics companies over the past week. We promise you'll be informed in less time than it takes to brew your coffee. New, Standard
Core One Labs Inc. (OTCMKTS:CLABF) Sees Significant Decrease in Short Interest
Core One Labs Inc. (OTCMKTS:CLABF – Get Rating) saw a significant drop in short interest in December. As of December 30th, there was short interest totalling 10,200 shares, a drop of 23.9% from the
Core One Acquires GMP Drug to Bolster Psychedelics Production
Core One Labs Inc. (OTCMKTS:CLABF) Sees Significant Growth in Short Interest
Core One Labs Inc. (OTCMKTS:CLABF – Get Rating) was the recipient of a significant growth in short interest in the month of December. As of December 15th, there was short interest totalling 13,400 sh
Psyched: Canada's Psychedelic Therapy Guidelines, $39M Series B For Next-Gen Drugs, Mexico's Ancestral Roots & More
Canada: Fed Guidelines For Psychedelic Therapy, Quebec Treatment Costs, Access And Magic Mushrooms Dispensaries The agency regulating all things related to psychedelic-assisted therapy (PAT), Health C
Psychedelic Mushrooms Soon To Be Commercially Produced And Sold In Canada
After a successful commercial production trial, life sciences biotech company Core One Labs Inc. (OTCQB:CLABF) is set to begin commercial production of its clinical-grade psilocybin at a Good Manufact
Short Interest in Core One Labs Inc. (OTCMKTS:CLABF) Drops By 37.4%
Core One Labs Inc. (OTCMKTS:CLABF – Get Rating) was the recipient of a large decline in short interest in the month of November. As of November 30th, there was short interest totalling 10,700 shares,
Psychedelics Developer & Mass-Scale Manufacturer Will Deliver Novel Magic Mushroom Products
Life sciences biotech company Core One Labs Inc. (OTCQB:CLABF) signed a Letter of Intent with GMP-certified manufacturer Medelys Laboratories International Inc. for the manufacturing of its proprietar
New Biosynthetic Psilocybin Hits The Psychedelics Market, Available For Research And Clinical Trials
With psilocybin among the favorites within psychedelics, Core One Labs Inc. (OTCQB:CLABF) is joining Optimi Health (OTC:OPTHF) to formally begin sales for its own biosynthetic API psilocybin product.
Core One Labs Inc. (OTCMKTS:CLABF) Short Interest Update
Core One Labs Inc. (OTCMKTS:CLABF – Get Rating) was the recipient of a significant growth in short interest during the month of July. As of July 31st, there was short interest totalling 15,200 shares
Core One Labs Inc. (OTCMKTS:CLABF) Short Interest Down 35.6% in May
Core One Labs Inc. (OTCMKTS:CLABF – Get Rating) was the target of a large decline in short interest during the month of May. As of May 15th, there was short interest totalling 5,600 shares, a decline
Core One Labs Inc. (OTCMKTS:CLABF) Short Interest Down 23.3% in March
Core One Labs Inc. (OTCMKTS:CLABF – Get Rating) saw a large decline in short interest in the month of March. As of March 31st, there was short interest totalling 9,900 shares, a decline of 23.3% from
Analysis
Price Target
No Data
